Page 73 - GALENIKA MEDICAL JOURNAL

Literatura 22. Wei S, Venn A, Ding C, Foley S, Laslett L, Jones G. The association
between oral contraceptive use, bone mineral density and fractures in
women aged 50-80 years. Contraception. 2011 Oct;84(4):357-62.
1. Medical Eligibility Criteria for Contraceptive Use. 5th ed. Geneva: World 23. Poromaa IS, Segebladh B. Adverse mood symptoms with oral
Health Organization; 2015. contraceptives. Acta Obstet Gynecol Scand 2012; 91:420-7.
2. Sedlecky K, Pantić Aksentijević S, Živanović A, Kapamadžija A, Mitrović 24. Gallo MF, Lopez LM, Grimes DA, Schulz KF, Helmerhorst FM.
Jovanović A, Relić G, et al. Kliničke smernice za kontracepciju. Preporuke Combination contraceptives: effects on weight. Cochrane Database Syst
za korišćenje kombinovane hormonske i intrauterine kontracepcije, Rev. 2006 Jan 25;(1):CD003987.
Beograd, 2020.
25. Collaborative Group on Hormonal Factors in Breast Cancer. Breast
3. Trussell J. Contraceptive efficacy. U: Hatcher RA, Trussell J, Nelson AL, cancer and hormonal contraceptives: collaborative reanalysis of
Cates W, Kowal D, Policar M (eds). Contraceptive technology: twentieth individual data on 53 297 women with breast cancer and 100 239
revised edition. New York (NY): Ardent Media; 2011. women without breast cancer from 54 epidemiological studies. Lancet
4. Killick SR, Eyong E, Elstein M. Ovarian follicular development in oral 1996; 347:1713-27.
contraceptive cycle. Fertil Steril 1987; 48:409-13. 26. Mørch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard
5. Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility, Ø. Contemporary Hormonal Contraception and the Risk of Breast
8th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. Cancer. N Engl J Med. 2017 Dec 7;377(23):2228-39.
6. Mavranezouli I, LARC Guideline Development Group. The cost- 27. Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort
effectiveness of long- acting reversible contraceptive methods in the study with special reference to oral contraceptive use. Contraception.
UK: analysis based on a decision-analytic model developed for a NICE 2010 Sep;82(3):221-9.
clinical practice guideline. Hum Reprod 2008; 23:1338-45. 28. Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, et al.
7. World Health Organization. Selected practice recommendations Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2
for contraceptive use. 3rd ed. Geneva: World Health Organization; mutation carriers. J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9.
2016. Available online: http://apps.who.int/iris/bitstre 29. Cancer and Steroid Hormones (CASH). Combined oral contraceptive use
am/10665/252267/1/9789241565400-eng.pdf?ua=1. and risk of endometrial cancer. JAMA 1987; 257:796-800.
8. Family Planning. A Global Handbook For Providers. Evidence-based 30. Reape KZ, DiLiberti CE, Hendy CH, Volpe EJ. Effects on serum hormone
guidance developed through worldwide collaboration. World Health levels of low-dose estrogen in place of placebo during the hormone-
Organization. Department of Reproductive Health and Research. Johns free interval of an oral contraceptive. Contraception. 2008 Jan;77(1):34-
Hopkins Bloomberg School of Public Health Center for Communication 9.
Programs. Knowledge for Health Project. United States Agency for
International Development. Bureau for Global Health. Office of 31. Huber JC, Heskamp ML, Schramm GA. Effect of an oral contraceptive
Population and Reproductive Health; 2011 Update. with chlormadinone acetate on depressive mood : analysis of data from
9. Faculty of Sexual and Reproductive Healthcare Clinical Guidance. four observational studies. Clin Drug Investig. 2008;28(12):783-91.
Intrauterine Contraception. 2015. Available online: https://www.fsrh. 32. Merki-Feld GS, Caetano C, Porz TC, Bitzer J. Are there unmet needs in
org/documents/ceuguidanceintrauterinecontraception/. contraceptive counselling and choice? Findings of the European TANCO
10. Apter D, Gemzell-Danielsson K, Hauck B, Rosen K, Zurth C. Study. Eur J Contracept Reprod Health Care. 2018 Jun;23(3):183-93.
Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine
systems and effects on ovulation rate and cervical function: pooled
analyses of phase II and III studies. Fertil Steril. 2014 Jun;101(6):1656- Konflikt interesa: Nema
62.e1-4.
11. Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel Primljeno: 10. 11. 2024.
intrauterine system: biological bases of their mechanism of action. Prihvaćeno: 20. 11. 2024.
Contraception 2007; 75(6 Suppl.):S16–S30. Onlajn: 31. 12. 2024.
12. Jones RL, Critchley HOD. Morphological and functional changes in
human endometrium following intrauterine levonorgestrel delivery.
Hum Reprod 2000; 15(Suppl.):162–72.
13. Hoaglin DC, Filonenko A, Glickman ME, Wasiak R, Gidwani R. Use
of mixed-treatment-comparison methods in estimating efficacy of
treatments for heavy menstrual bleeding. Eur J Med Res. 2013 Jun
21;18(1):17.
14. Xiao B, Wu SC, Chong J, Zeng T, Han LH, Luukkainen T. Therapeutic
effects of the levonorgestrel-releasing intrauterine system in the
treatment of idiopathic menorrhagia. Fertil Steril. 2003 Apr;79(4):963-9.
15. Xu L, Lee BS, Asif S, Kraemer P, Inki P. Satisfaction and health-related
quality of life in women with heavy menstrual bleeding; results from
a non-interventional trial of the levonorgestrel-releasing intrauterine
system or conventional medical therapy. Int J Womens Health. 2014
May 27;6:547-54.
16. Heinemann LAJ, Dinger JC. Range of published estimates of venous
thromboembolism incidence in young women. Contraception 2007;
75:328-36.
17. Dinger JC, Heinemann LAJ, Kuhl-Habichl D. The safety of drospirenone-
containing oral contraceptive: final results from the European Active
Surveillance study on Oral Contraceptives based on 142,475 women-
years of observation. Contraception 2007; 75:344-54.
18. Lanes SF, Birman B, Walker AM, Singer S. Oral contraceptive type and
functional ovarian cysts. Am J Obstet Gynaecol 1992; 166:956-61.
19. Westhoff C, Britton JA, Gammon MD, Wright T, Kelsey JL. Oral
contraceptive and benign ovarian tumors. Am J Epidemiol. 2000 Aug
1;152(3):242-6.
20. Hannaford P, Elliot A. Use of exogenous hormones by women and
colorectal cancer: evidence from the Royal College of General
Practitioner’s Oral Contraception Study. Contraception 2005; 71:95-8.
21. Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M. Steroidal
contraceptives: effect on bone fractures in women. Cochrane Database
Syst Rev. 2014 Jun 24;2014(6):CD006033.

REVIJALNI RADOVI Galenika Medical Journal, 2024; 3(12):65-71. 71